Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Axis-shield

Axis-Shield is active in several key clinical areas where the development of suitable diagnostics is acknowledged to have a potential beneficial effect on outcomes.

KEY CLINICAL AREAS -



CARDIOVASCULAR DISEASE

CEREBROVASCULAR DISEASE AND DEMENTIA

AUTOIMMUNE DISEASE

ALCOHOL-RELATED DISEASE

DIABETES

INFECTIOUS DISEASES

TARGETING INNOVATION -



MANY NOVEL PROPRIETARY ANALYTES

NEW POINT-OF-CARE TECHNOLOGIES

EXPLOITING GENETIC ADVANCES

EMBRACING E-HEALTH APPLICATIONS

EXPLORING ALLIANCES IN DISEASE MANAGEMENT


Contact Details:
Technology Park
Dundee
Tayside
DD2 2AX
United Kingdom
Tel:01382 422000
Fax:01382 422088
Email:

Loading...

Recent Publications by Axis-shield:

Active B12: a rapid, automated assay for holotranscobalamin on the Abbott AxSYM analyzer.
BACKGROUND: Conventional tests for vitamin B(12) deficiency measure total...
14th May, 2008
Axis-Shield Diagnostics, Ltd., Dundee, Scotland, UK. Clin Chem. 2008 Mar;54(3):567-73. Epub 2008 Jan 4.
DOI Direct Link
Up close and personal: molecular diagnostics in oncology.
The almost overwhelming volume of information and new technological...
15th April, 2005
Tumour Biol. 2004 Jul-Aug;25(4):217-20.
DOI Direct Link
Interfering with cancer: a brief outline of advances in RNA interference in oncology.
RNA interference (RNAi) is a potent and ubiquitous gene-silencing...
22nd January, 2005
Axis Shield ASA, Ulvenveien 87, NO-0581 Oslo, Norway. Tumour Biol. 2004 Sep-Dec;25(5-6):329-36.
DOI Direct Link
The bioinformatic catalyst in the kallikrein family.
RNA interference (RNAi) is a potent and ubiquitous gene-silencing...
22nd January, 2005
Axis-Shield ASA, Ulvenveien 87, NO-0581 Oslo, Norway. Tumour Biol. 2004 Sep-Dec;25(5-6):327-8.
DOI Direct Link
Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies.
Although the role of citrullinated peptides in the pathogenesis of RA is...
26th November, 2002
Axis-Shield Diagnostics Ltd., Technology Park, Dundee, DD2 1XA, U.K. Am Clin Lab. 2002 Aug-Sep;21(7):34-6.

View more Axis-shield research publications.

BioNews Results for Axis-shield:

Event Report : The Sustainable Laboratory Workshop (12 November 2009)
BioDundee:  Nov 12 2009 9:11PM Matching: axis shield
Chemiluminescent Microparticle Immunoassay Helps Diagnose Rheumatoid Arthritis
Lab Medica:  Nov 6 2009 4:19PM Matching: axis shield
FDA Clears SQI Diagnostics' Array-Based RA Test for Sale in US
GenomeWeb:  Nov 3 2009 11:08PM Matching: axis shield
Abbott wins FDA approval for new test to diagnose rheumatoid arthritis
Pharmacy Choice:  Oct 22 2009 5:38PM Matching: axis shield
US FDA approves new test to aid in diagnosis of rheumatoid arthritis
PharmaBiz:  Oct 22 2009 12:22PM Matching: axis shield
Promote your company here: BioNewsCast - Press Release Distribution

View more Axis-shield news.

Axis-shield Clinical Trials:

Risk Markers in the Acute Coronary Syndromes

Axis-shield Patents:

US Patent No.Title
7592182 Assay
6063581 Immunoassay for homocysteine
6103478 CDT assay
6716641 Dipstick for carbohydrate-free transferrin assay
7166473 Transferrin assay

View more Axis-shield patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 338 times since April 2007, the link to the organisation's website has been followed 0 times

Search for more companies in Dundee

Search for more companies in Tayside



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Axis-shield

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.